Vivos RDGL
OTC RDGL
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vivos (RDGL) Payables (2010 - 2025)

Vivos' (RDGL) quarterly Payables came in at $92472.0 in Q4 2025, up 7.26% year-over-year from $86209.0 in Q4 2024, and down 17.94% quarter-over-quarter from $112693.0 in Q3 2025.

Analysis

Vivos (RDGL) Payables (2010 - 2025) Analysis & Trends

Vivos has disclosed Payables across 16 years of filings, most recently posting $92472.0 for Q4 2025.

  • In Q4 2025, Payables rose 7.26% year-over-year to $92472.0; the TTM figure through Dec 2025 stood at $92472.0 (up 7.26% YoY), while the FY2025 annual figure was $92472.0, up 7.26% from the prior year.
  • Payables came in at $92472.0 for Q4 2025 at Vivos, down from $112693.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $443345.0 in Q1 2021 to a low of $48820.0 in Q3 2024.
  • Average Payables over 5 years is $163738.0, with a median of $112751.5 recorded in 2023.
  • Year-over-year, Payables slumped 80.71% in 2022 and soared 199.91% in 2023.
  • Over 5 years, Payables stood at $166915.0 in 2021, then sank by 51.06% to $81692.0 in 2022, then soared by 199.91% to $245004.0 in 2023, then plunged by 64.81% to $86209.0 in 2024, then increased by 7.26% to $92472.0 in 2025.
  • Per Business Quant data, the three most recent Payables figures were $92472.0 in Q4 2025, $112693.0 in Q3 2025, and $96458.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 5.89 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 277.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 2.70 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 2.00 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 1.23 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 210.50 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 968.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 587.50 Mn
10 Vivos 23.21 Mn 23.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 92,472.00
Sep 30, 2025 112,693.00
Jun 30, 2025 96,458.00
Mar 31, 2025 115,378.00
Dec 31, 2024 86,209.00
Sep 30, 2024 48,820.00
Jun 30, 2024 166,560.00
Mar 31, 2024 74,766.00
Dec 31, 2023 245,004.00
Sep 30, 2023 107,369.00
Jun 30, 2023 112,810.00
Mar 31, 2023 48,989.00
Dec 31, 2022 81,692.00
Sep 30, 2022 160,953.00
Jun 30, 2022 215,093.00
Mar 31, 2022 85,515.00
Dec 31, 2021 166,915.00
Sep 30, 2021 409,652.00
Jun 30, 2021 404,068.00
Mar 31, 2021 443,345.00